Literature DB >> 10967562

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation.

M Mohty1, C Faucher, N Vey, A M Stoppa, F Viret, I Chabbert, C Chabannon, R Bouabdallah, P Ladaique, L Collet, C Zandotti, D Maraninchi, D Blaise.   

Abstract

New approaches using nonmyeloablative-conditioning regimens have been developed to cause minimal procedure-related toxicity. Such novel therapeutic options are being explored with good preliminary results concerning feasibility and engraftment. However many aspects remain under-evaluated, and few data are available about viral and nonviral infections after these highly immunosuppressive regimens. We present our preliminary data on 21 patients receiving a highly immunosuppressive conditioning strategy, focusing on early infectious complications. Early viral infections before day 45, especially CMV, occurred at a high rate (65%). Furthermore, 33% of patients presented with late bacterial infections (predominately gram negative) although they were not neutropenic compared to conventional conditioning regimens. Although there is presently real interest in these new conditioning regimens which result in reduced immediate transplant-related mortality, it is important that investigators be aware of these pitfalls which may secondarily increase transplant toxicity. Further studies are needed to confirm these findings.

Entities:  

Mesh:

Year:  2000        PMID: 10967562     DOI: 10.1038/sj.bmt.1702509

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

1.  Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen.

Authors:  Joanna M Schaenman; Sumana Shashidhar; Chanu Rhee; Jonathan Wong; Shelly Navato; Ruby M Wong; Dora Y Ho; Sally Arai; Laura Johnston; Janice M Brown
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-22       Impact factor: 5.742

2.  A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.

Authors:  Haruhiko Kashiwazaki; Takae Matsushita; Junichi Sugita; Akio Shigematsu; Kumiko Kasashi; Yutaka Yamazaki; Takashi Kanehira; Takeshi Kondo; Tomoyuki Endo; Junji Tanaka; Satoshi Hashino; Mitsufumi Nishio; Masahiro Imamura; Yoshimasa Kitagawa; Nobuo Inoue
Journal:  Support Care Cancer       Date:  2011-04-15       Impact factor: 3.603

3.  Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.

Authors:  Y Wang; H-X Fu; D-H Liu; L-P Xu; X-H Zhang; Y-J Chang; Y-H Chen; F-R Wang; Y-Q Sun; F-F Tang; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2013-12-02       Impact factor: 5.483

4.  The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.

Authors:  Lynn El Haddad; Ella Ariza-Heredia; Dimpy P Shah; Ying Jiang; Ted Blanchard; Shashank S Ghantoji; Firas El Chaer; Danielle El-Haddad; Amrita Prayag; Lior Nesher; Katy Rezvani; Elizabeth Shpall; Roy F Chemaly
Journal:  J Infect Dis       Date:  2019-02-23       Impact factor: 5.226

Review 5.  Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies.

Authors:  S Fadilah Abdul Wahid
Journal:  Int J Hematol       Date:  2013-04-13       Impact factor: 2.490

Review 6.  Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy.

Authors:  Paolo Anderlini; Richard Champlin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge.

Authors:  Kieren A Marr
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

8.  Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.

Authors:  Seok Lee; Si-Hyun Kim; Su-Mi Choi; Dong-Gun Lee; Sung-Yong Kim; Jong-Wook Lee; Woo-Sung Min; Wan-Shik Shin; Chun-Choo Kim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

Review 9.  The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.

Authors:  Michael Maris; Rainer Storb
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  The risk of cytomegalovirus infection in non-myeloablative peripheral stem cell transplantation compared with conventional bone marrow transplantation.

Authors:  Suk Joong Oh; Kyoo Hyung Lee; Je Hwan Lee; Seong Jun Choi; Woo Kun Kim; Jung Shin Lee; Mi Na Kim
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.